Squarepoint’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.11M Buy
198,763
+150,655
+313% +$3.49M 0.01% 1584
2026
Q1
$990K Buy
+48,108
New +$1.08M ﹤0.01% 2788
2025
Q4
Sell
-111,311
Closed -$2.77M 4749
2025
Q3
$2.77M Buy
111,311
+91,056
+450% +$1.96M ﹤0.01% 1845
2025
Q2
$466K Sell
20,255
-54,665
-73% -$1.27M ﹤0.01% 3332
2025
Q1
$1.68M Buy
+74,920
New +$1.74M ﹤0.01% 2235
2024
Q3
Sell
-23,985
Closed -$417K 4572
2024
Q2
$417K Buy
+23,985
New +$425K ﹤0.01% 3217
2023
Q3
Sell
-68,251
Closed -$1.78M 4138
2023
Q2
$1.78M Buy
68,251
+32,850
+93% +$868K 0.01% 1730
2023
Q1
$977K Sell
35,401
-119,607
-77% -$3.16M ﹤0.01% 1904
2022
Q4
$3.52M Buy
155,008
+115,820
+296% +$3.22M 0.01% 1019
2022
Q3
$1.33M Buy
+39,188
New +$1.45M 0.01% 1574
2022
Q1
Sell
-10,617
Closed -$275K 3377
2021
Q4
$275K Sell
10,617
-266
-2% -$6.63K ﹤0.01% 2496
2021
Q3
$256K Buy
10,883
+3,481
+47% +$122K ﹤0.01% 2343
2021
Q2
$328K Buy
+7,402
New +$273K ﹤0.01% 2463

Other funds holding PRVA

Squarepoint's PRVA Position: Q2 2026 in Review

Squarepoint increased its Privia Health (PRVA) stake by 313% in Q2 2026, buying an estimated $3.49M and bringing the position to 198,763 shares worth $5.11M. The position accounts for 0.01% of the portfolio, ranked #1584.

Squarepoint first reported a position in PRVA in Q2 2021 and has held it in 13 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Squarepoint held 198,763 shares of Privia Health worth $5.11M as of Q2 2026.
  • Squarepoint bought 150,655 Privia Health shares in Q2 2026, an estimated $3.49M.
  • Privia Health made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1584 holding.
  • Squarepoint first reported a position in Privia Health in Q2 2021 and has held it in 13 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.